Prostatic Hypertrophy, Benign Completed Phase 1 Trials for Tadalafil (DB00820)

Also known as: Benign Prostatic Hypertrophy (BPH) / Benign Prostatic Hypertrophy / BPH / Prostatic hypertrophy (benign) / Benign prostatic hyperplasia / Enlarged prostate (benign)

IndicationStatusPhase
DBCOND0029457 (Prostatic Hypertrophy, Benign)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02615782A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male SubjectsTreatment